The US Food and Narcotics Administration (FDA) has just released a new update in connection with the treatment option for Covid-19. As a result of updates, the FDA has removed authorization for two monoclonal antibody treatments. Starting January 24, 2022, this treatment will only be authorized in certain regions.
In the statement posted on the FDA website, further information was disclosed about…